{"id":148521,"date":"2021-05-30T18:27:59","date_gmt":"2021-05-30T15:27:59","guid":{"rendered":"https:\/\/www.vaikuttavuussaatio.fi\/?p=148521"},"modified":"2023-04-22T13:17:39","modified_gmt":"2023-04-22T10:17:39","slug":"immunotherapy-can-revolutionize-the-cancer-therapy-market","status":"publish","type":"post","link":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/","title":{"rendered":"Immunotherapy can revolutionize the cancer therapy market"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.vaikuttavuussaatio.fi\/en\/the-finnish-research-impact-foundations-annual-report-2020\/\">\u00ab back to Annual Report<\/a><\/p>\n\n\n\n<div class=\"wp-block-ugb-container ugb-container ugb-0765ad3 ugb-container--v2 ugb-container--design-plain ugb-main-block\"><style>@media screen and (min-width:768px){.ugb-0765ad3 > .ugb-inner-block > .ugb-block-content > *{padding-top:20px !important;padding-bottom:20px !important}}<\/style><div class=\"ugb-inner-block\"><div class=\"ugb-block-content\"><div class=\"ugb-container__wrapper ugb-0765ad3-wrapper\"><div class=\"ugb-container__side\"><div class=\"ugb-container__content-wrapper ugb-0765ad3-content-wrapper\">\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:23% auto\"><figure class=\"wp-block-media-text__media\"><img decoding=\"async\" width=\"998\" height=\"1024\" data-src=\"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-998x1024.jpg\" alt=\"\" class=\"wp-image-148374 size-full lazyload\" data-srcset=\"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-998x1024.jpg 998w, https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-292x300.jpg 292w, https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-768x788.jpg 768w, https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg 1233w\" data-sizes=\"(max-width: 998px) 100vw, 998px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 998px; --smush-placeholder-aspect-ratio: 998\/1024;\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"wp-block-paragraph\">Project title: Improving immuno-oncology tools to fight cancer: the use of complex immune organoids for testing the efficacy of peptides coated oncolytic viruses (PeptiCRAd \/ PeptiENV)<br>Academic partner: University of Helsinki<br>Principal investigator: Professor Vincenzo Cerullo<br>Postdoc researcher: Mikaela Gr\u00f6nholm<br>Industry partner: Valo Therapeutics<\/p>\n<\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><em><em>The Finnish start-up company Valo Therapeutics and the Immuno Viro Therapy lab at the University of Helsinki are working to develop a 3D model that can predict the effects of immunotherapy in individual patients.<\/em><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Common usage often classifies cancers based on their site of origin in the body: breast cancer, lung cancer, skin cancer. However, the same cancer can be a very different disease for different individuals.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cIn fact it\u2019s true to say that every patient has their own disease,\u201d says oncology researcher <strong>Mikaela Gr\u00f6nholm<\/strong> from the Immuno Viro Therapy team at the University of Helsinki. This is why the current therapeutic approach of destroying the tumour at a certain body site is becoming outdated. A new strategy is emerging with the evolution of immunotherapy, which is focused on activating the patient\u2019s own immune system.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Immunotherapy has achieved excellent results in the treatment of melanoma or skin cancer, for instance. But Mikaela says there are currently two obstacles to the wider adoption of immunotherapy: \u201cWe still know very little about who can benefit from the therapy and who can\u2019t. And secondly, developing and testing treatments is an expensive process and we don\u2019t yet have good testing models in place.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Finnish start-up company Valo Therapeutics is working closely with the Immuno Viro Therapy team at the University of Helsinki to find a solution to this testing problem. They are growing 3D mini-tumours that include both cancer tissue, the cancer microenvironment and the patient\u2019s own immune cells. The team are also involved in the Academy of Finland\u2019s iCAN cancer flagship project (Digital Precision Medicine platform).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It is noteworthy that the model is entirely anthropogenic and therefore works in the exact same way as in the human body. \u201cThe model will benefit everyone working on immunotherapy,\u201d says Mikaela Gr\u00f6nholm, who is involved in the project as postdoc researcher.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Business cooperation opens up interesting research questions<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Gr\u00f6nholm says that collaboration between an academic partner and a start-up company brings together the unique strengths of both parties and for the researcher provides an excellent vantage point over the way the business operates. \u201cIn the academic world you\u2019re allowed to take risks, to be curious and to experiment, whereas a business will set specific targets for research and formulate research questions that are interesting from a drug development point of view.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">When researchers get to work with a start-up company, they also get the opportunity to influence and express their views about the technology under development. \u201cI\u2019m involved in creating tools that are immediately put to use in the company.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Gr\u00f6nholm believes that collaborations between academia and business companies could&nbsp;still be expanded. That is why incentives such as FRIF\u2019s Tandem funding scheme are so important.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Promising results from collaboration<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The 3D model created by Valo Therapeutics and the University of Helsinki team is applicable to all aspects of immunotherapy development. What is more, the project will provide crucial information about the applicability of immunotherapy for different people. It makes use of the oncolytic viruses manufactured by Valo Therapeutics, which trigger the organism\u2019s immune responses in the body. The team have now been using these viruses to test their model, and the results are promising. The next step is to raise the bar and enter more variables into the model.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Start-up companies and researchers both share a strong passion for problem-solving. \u201cIt\u2019s unbelievable what cancer can do to the body. That is what makes cancer research so fascinating and so challenging. I want to find ways to cure cancer,\u201d Gr\u00f6nholm says.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Finnish start-up company Valo Therapeutics and the Immuno Viro Therapy lab at the University of Helsinki are working to develop a 3D model that can predict the effects of immunotherapy in individual patients.<\/p>\n","protected":false},"author":1,"featured_media":148375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":true,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[20],"tags":[],"class_list":["post-148521","post","type-post","status-publish","format-standard","has-post-thumbnail","category-annual-report-2020","entry"],"featured_image_url":{"thumbnail":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-150x150.jpg","medium":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-292x300.jpg","medium_large":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-768x788.jpg","large":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-998x1024.jpg","1536x1536":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","2048x2048":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","sidebar-featured":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-75x75.jpg","genesis-singular-images":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-702x526.jpg","ab-block-post-grid-landscape":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","ab-block-post-grid-square":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","gb-block-post-grid-landscape":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-600x400.jpg","gb-block-post-grid-square":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-600x600.jpg"},"post_author":"vaikuttavuussaatio","assigned_categories":"Annual Report 2020","featured_image_urls_v2":{"full":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg",1233,1265,false],"thumbnail":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-150x150.jpg",150,150,true],"medium":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-292x300.jpg",292,300,true],"medium_large":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-768x788.jpg",768,788,true],"large":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-998x1024.jpg",998,1024,true],"1536x1536":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg",1233,1265,false],"2048x2048":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg",1233,1265,false],"sidebar-featured":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-75x75.jpg",75,75,true],"genesis-singular-images":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-702x526.jpg",702,526,true],"ab-block-post-grid-landscape":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg",390,400,false],"ab-block-post-grid-square":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg",585,600,false],"gb-block-post-grid-landscape":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-600x400.jpg",600,400,true],"gb-block-post-grid-square":["https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-600x600.jpg",600,600,true]},"post_excerpt_stackable_v2":"<p>The Finnish start-up company Valo Therapeutics and the Immuno Viro Therapy lab at the University of Helsinki are working to develop a 3D model that can predict the effects of immunotherapy in individual patients.<\/p>\n","category_list_v2":"<a href=\"https:\/\/www.vaikuttavuussaatio.fi\/en\/category\/annual-report-2020\/\" rel=\"category tag\">Annual Report 2020<\/a>","author_info_v2":{"name":"vaikuttavuussaatio","url":"https:\/\/www.vaikuttavuussaatio.fi\/en\/author\/vaikuttavuussaatio\/"},"comments_num_v2":"0 comments","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunotherapy can revolutionize the cancer therapy market - Vaikuttavuussaatio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunotherapy can revolutionize the cancer therapy market - Vaikuttavuussaatio\" \/>\n<meta property=\"og:description\" content=\"The Finnish start-up company Valo Therapeutics and the Immuno Viro Therapy lab at the University of Helsinki are working to develop a 3D model that can predict the effects of immunotherapy in individual patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Vaikuttavuussaatio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/vaikuttavuussaatio\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-30T15:27:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-22T10:17:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1233\" \/>\n\t<meta property=\"og:image:height\" content=\"1265\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"vaikuttavuussaatio\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@tvtsaatio\" \/>\n<meta name=\"twitter:site\" content=\"@tvtsaatio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"vaikuttavuussaatio\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/\"},\"author\":{\"name\":\"vaikuttavuussaatio\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#\\\/schema\\\/person\\\/15f8fb4880f7224603bd17560a755f68\"},\"headline\":\"Immunotherapy can revolutionize the cancer therapy market\",\"datePublished\":\"2021-05-30T15:27:59+00:00\",\"dateModified\":\"2023-04-22T10:17:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/\"},\"wordCount\":658,\"publisher\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/mikaela.jpg\",\"articleSection\":[\"Annual Report 2020\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/\",\"url\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/\",\"name\":\"Immunotherapy can revolutionize the cancer therapy market - Vaikuttavuussaatio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/mikaela.jpg\",\"datePublished\":\"2021-05-30T15:27:59+00:00\",\"dateModified\":\"2023-04-22T10:17:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/mikaela.jpg\",\"contentUrl\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/mikaela.jpg\",\"width\":1233,\"height\":1265},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/immunotherapy-can-revolutionize-the-cancer-therapy-market\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunotherapy can revolutionize the cancer therapy market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/\",\"name\":\"Vaikuttavuussaatio\",\"description\":\"Vaikuttavuuss\u00e4\u00e4ti\u00f6 vahvistaa ja tukee huippututkimuksen vaikuttavuutta ja elinkeinoel\u00e4m\u00e4n yhteyksi\u00e4.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#organization\",\"name\":\"Vaikuttavuuss\u00e4\u00e4ti\u00f6\",\"url\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/logo.png\",\"width\":398,\"height\":362,\"caption\":\"Vaikuttavuuss\u00e4\u00e4ti\u00f6\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/vaikuttavuussaatio\\\/\",\"https:\\\/\\\/x.com\\\/tvtsaatio\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/#\\\/schema\\\/person\\\/15f8fb4880f7224603bd17560a755f68\",\"name\":\"vaikuttavuussaatio\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7924181a3a839c84b4a942d8f3db9b38141fc63145e8c75f2891303c7684b2fd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7924181a3a839c84b4a942d8f3db9b38141fc63145e8c75f2891303c7684b2fd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7924181a3a839c84b4a942d8f3db9b38141fc63145e8c75f2891303c7684b2fd?s=96&d=mm&r=g\",\"caption\":\"vaikuttavuussaatio\"},\"url\":\"https:\\\/\\\/www.vaikuttavuussaatio.fi\\\/en\\\/author\\\/vaikuttavuussaatio\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunotherapy can revolutionize the cancer therapy market - Vaikuttavuussaatio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/","og_locale":"en_US","og_type":"article","og_title":"Immunotherapy can revolutionize the cancer therapy market - Vaikuttavuussaatio","og_description":"The Finnish start-up company Valo Therapeutics and the Immuno Viro Therapy lab at the University of Helsinki are working to develop a 3D model that can predict the effects of immunotherapy in individual patients.","og_url":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/","og_site_name":"Vaikuttavuussaatio","article_publisher":"https:\/\/www.facebook.com\/vaikuttavuussaatio\/","article_published_time":"2021-05-30T15:27:59+00:00","article_modified_time":"2023-04-22T10:17:39+00:00","og_image":[{"width":1233,"height":1265,"url":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","type":"image\/jpeg"}],"author":"vaikuttavuussaatio","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","twitter_creator":"@tvtsaatio","twitter_site":"@tvtsaatio","twitter_misc":{"Written by":"vaikuttavuussaatio","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/#article","isPartOf":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/"},"author":{"name":"vaikuttavuussaatio","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#\/schema\/person\/15f8fb4880f7224603bd17560a755f68"},"headline":"Immunotherapy can revolutionize the cancer therapy market","datePublished":"2021-05-30T15:27:59+00:00","dateModified":"2023-04-22T10:17:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/"},"wordCount":658,"publisher":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#organization"},"image":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","articleSection":["Annual Report 2020"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/","url":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/","name":"Immunotherapy can revolutionize the cancer therapy market - Vaikuttavuussaatio","isPartOf":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/#primaryimage"},"image":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","datePublished":"2021-05-30T15:27:59+00:00","dateModified":"2023-04-22T10:17:39+00:00","breadcrumb":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/#primaryimage","url":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","contentUrl":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela.jpg","width":1233,"height":1265},{"@type":"BreadcrumbList","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/immunotherapy-can-revolutionize-the-cancer-therapy-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vaikuttavuussaatio.fi\/en\/"},{"@type":"ListItem","position":2,"name":"Immunotherapy can revolutionize the cancer therapy market"}]},{"@type":"WebSite","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#website","url":"https:\/\/www.vaikuttavuussaatio.fi\/en\/","name":"Vaikuttavuussaatio","description":"Vaikuttavuuss\u00e4\u00e4ti\u00f6 vahvistaa ja tukee huippututkimuksen vaikuttavuutta ja elinkeinoel\u00e4m\u00e4n yhteyksi\u00e4.","publisher":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vaikuttavuussaatio.fi\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#organization","name":"Vaikuttavuuss\u00e4\u00e4ti\u00f6","url":"https:\/\/www.vaikuttavuussaatio.fi\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2020\/02\/logo.png","contentUrl":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2020\/02\/logo.png","width":398,"height":362,"caption":"Vaikuttavuuss\u00e4\u00e4ti\u00f6"},"image":{"@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/vaikuttavuussaatio\/","https:\/\/x.com\/tvtsaatio"]},{"@type":"Person","@id":"https:\/\/www.vaikuttavuussaatio.fi\/en\/#\/schema\/person\/15f8fb4880f7224603bd17560a755f68","name":"vaikuttavuussaatio","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7924181a3a839c84b4a942d8f3db9b38141fc63145e8c75f2891303c7684b2fd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7924181a3a839c84b4a942d8f3db9b38141fc63145e8c75f2891303c7684b2fd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7924181a3a839c84b4a942d8f3db9b38141fc63145e8c75f2891303c7684b2fd?s=96&d=mm&r=g","caption":"vaikuttavuussaatio"},"url":"https:\/\/www.vaikuttavuussaatio.fi\/en\/author\/vaikuttavuussaatio\/"}]}},"featured_image_src":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-600x400.jpg","featured_image_src_square":"https:\/\/www.vaikuttavuussaatio.fi\/wp-content\/uploads\/2021\/04\/mikaela-600x600.jpg","author_info":{"display_name":"vaikuttavuussaatio","author_link":"https:\/\/www.vaikuttavuussaatio.fi\/en\/author\/vaikuttavuussaatio\/"},"_links":{"self":[{"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/posts\/148521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/comments?post=148521"}],"version-history":[{"count":0,"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/posts\/148521\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/media\/148375"}],"wp:attachment":[{"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/media?parent=148521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/categories?post=148521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vaikuttavuussaatio.fi\/en\/wp-json\/wp\/v2\/tags?post=148521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}